Dashboard
Manage Tickers

BPMC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

sanofi-expands-respiratory-vaccine-portfolio-with-uk-biotech-buy
Sanofi Expands Respiratory Vaccine Portfol...
07/22/2025 18:09:38

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...

trading-halt-halt-status-updated-at-84500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:45:...
07/17/2025 12:45:04

whats-driving-the-market-sentiment-around-blueprint-medicines
What's Driving the Market Sentiment Around...
07/14/2025 19:01:04

cogents-chronic-immune-disorder-drug-has-strong-potential-to-become-a-blockbuster-analyst
Cogent's Chronic Immune Disorder Drug Has ...
07/08/2025 18:26:44

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end...

wells-fargo-downgrades-blueprint-medicines-to-equal-weight-lowers-price-target-to-129
Wells Fargo Downgrades Blueprint Medicines...
06/18/2025 12:50:52

Wells Fargo analyst Derek Archila downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and lowers th...

nvidia-to-rally-more-than-38-here-are-10-top-analyst-forecasts-for-tuesday
Nvidia To Rally More Than 38%? Here Are 10...
06/17/2025 14:00:22

wells-fargo-downgrades-blueprint-medicines-to-equal-weight-lowers-price-target-to-129
Wells Fargo Downgrades Blueprint Medicines...
06/17/2025 13:42:16

Wells Fargo analyst Derek Archila downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and lowers th...

blueprint-medicines-reveals-data-reinforcing-sustained-clinical-efficacy-and-well-tolerated-safety-profile-of-long-term-ayvakitayvakyt-treatment-at-2025-eha-and-eaaci-congresses
Blueprint Medicines Reveals Data Reinforci...
06/12/2025 22:04:53

applied-digital-and-riot-platforms-are-among-top-10-mid-cap-gainers-last-week-jun-2-jun-6-are-the-others-in-your-portfolio
Applied Digital And Riot Platforms Are Amo...
06/08/2025 15:45:33

deal-dispatch-tv-stations-for-sale-this-buyer-wants-seconds-on-pasta
Deal Dispatch: TV Stations For Sale, This ...
06/06/2025 19:37:15

Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates.

morgan-stanley-maintains-equal-weight-on-blueprint-medicines-raises-price-target-to-129
Morgan Stanley Maintains Equal-Weight on B...
06/05/2025 17:39:50

Morgan Stanley analyst Judah Frommer maintains Blueprint Medicines (NASDAQ:BPMC) with a Equal-Weight and raises the price ta...

ubs-maintains-neutral-on-blueprint-medicines-raises-price-target-to-129
UBS Maintains Neutral on Blueprint Medicin...
06/05/2025 12:51:21

UBS analyst David Dai maintains Blueprint Medicines (NASDAQ:BPMC) with a Neutral and raises the price target from $88 to $129.

this-snowflake-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday
This Snowflake Analyst Turns Bullish; Here...
06/04/2025 13:37:15

citigroup-upgrades-blueprint-medicines-to-neutral-raises-price-target-to-129
Citigroup Upgrades Blueprint Medicines to ...
06/04/2025 12:35:04

Citigroup analyst David Lebowitz upgrades Blueprint Medicines (NASDAQ:BPMC) from Sell to Neutral and raises the price target...

jmp-securities-downgrades-blueprint-medicines-to-market-perform
JMP Securities Downgrades Blueprint Medici...
06/03/2025 14:12:59

JMP Securities analyst Reni Benjamin downgrades Blueprint Medicines (NASDAQ:BPMC) from Market Outperform to Market Perform.

this-asml-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This ASML Analyst Is No Longer Bullish; He...
06/03/2025 13:20:29

this-salesforce-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday
This Salesforce Analyst Begins Coverage On...
06/03/2025 13:11:50

stephens--co-downgrades-blueprint-medicines-to-equal-weight-lowers-price-target-to-135
Stephens & Co. Downgrades Blueprint Medici...
06/03/2025 11:11:18

Stephens & Co. analyst Sudan Loganathan downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and...

wolfe-research-downgrades-blueprint-medicines-to-peer-perform
Wolfe Research Downgrades Blueprint Medici...
06/03/2025 11:05:30

Wolfe Research analyst Andy Chen downgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Peer Perform.

scotiabank-downgrades-blueprint-medicines-to-sector-perform-announces-135-price-target
Scotiabank Downgrades Blueprint Medicines ...
06/02/2025 17:28:01

Scotiabank analyst Louise Chen downgrades Blueprint Medicines (NASDAQ:BPMC) from Sector Outperform to Sector Perform and ann...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION